Get started
Author

N. Den Broeder

Observed names: N. den Broeder, N.den Broeder
OpenAlex ID: A5036053113
Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs
2024 · M. A. A. Opdam, N.den Broeder, et al. · Clinical Rheumatology · 15
PDF
Pos0652 Long-term Effectiveness of Ultra-low Doses of Rituximab in Rheumatoid Arthritis
2022 · N. Den Broeder, L.M. Verhoef, et al. · Annals of the Rheumatic Diseases · 2
PDF
Pos0646 Non-medical Switching From Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients With Low Disease Activity
2022 · N. Den Broeder, A. Den Broeder, et al. · Annals of the Rheumatic Diseases · 2
PDF
Pos1207 Seroconversion After a Third Covid-19 Vaccination in Rheumatoid Arthritis Patients Treated With (ultra-)low Dose Rituximab With a Previous Insufficient Humoral Response Is Dependent on Rituximab Dosage
2022 · C. Van der Togt, D. Ten Cate, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos0269 Results of One Year Observational Extension of the Bridge-pmr Study, a Randomized Double-blind Placebo Controlled Trial With Rituximab in Polymyalgia Rheumatica.
2022 · T. Bolhuis, D. Marsman, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos1161 Predictive Value of Adalimumab (anti-) Drug Levels for Successful Tapering and Discontinuation of Adalimumab in Patients With Psoriatic Arthritis and Axial Spondyloarthritis
2025 · A.C.D. Peeters, N. den Broeder, et al. · Annals of the Rheumatic Diseases
Pos0891 Continuation Versus Temporary Interruption of Immunomodulatory Agents During Infections: Preliminary Results of a Randomized Controlled Trial in 1142 Patients With Inflammatory Arthritis
2024 · M. Opdam, N. Den Broeder, et al. · Annals of the Rheumatic Diseases
Pos1070 Slightly Increased Infection Risk for Jak Inhibitors Tofacitinib and Baricitinib Compared to Bdmards: a Real-world Evidence Study
2023 · M. Opdam, N. Den Broeder, et al. · Annals of the Rheumatic Diseases
PDF
POS0078 COMPARING METHOTREXATE MONOTHERAPY WITH METHOTREXATE PLUS LEFLUNOMIDE COMBINATION THERAPY IN PSORIATIC ARTHRITIS: A RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL (COMPLETE-PsA)
2022 · M.L.M. Mulder, J.E. Vriezekolk, et al. · Annals of the Rheumatic Diseases
PDF
Op0261 Treat-to-target Dose Reduction and Withdrawal Strategy of Tnf Inhibitors in Psoriatic Arthritis and Axial Spondyloarthritis: a Randomized Controlled Non-inferiority Trial
2022 · C. Michielsens, N. den Broeder, et al. · Annals of the Rheumatic Diseases
PDF
Pos0125 Extra-articular Findings With Fdg-pet/ct in Rheumatoid Arthritis Patients: More Harm Than Benefit.
2022 · E. Ulijn, A. Den Broeder, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 11
Citation count: 21
H-index: 2
I10-index: 1
Year
Topic
Type